Understanding how bone cells sense mechanical forces
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
This study looks at how bone cells react to pressure and talk to each other, and it also checks how the medication gabapentin might affect bone health, which could help improve treatments for people with bone issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10428360 on NIH RePORTER |
What this research studies
This research investigates how osteocytes, the primary cells in bone, respond to mechanical forces and communicate with other bone cells. By examining a specific complex that connects the bone matrix to the cell membrane, the study aims to uncover the mechanisms behind bone strength and formation. The research also explores the effects of gabapentin, a common medication, on bone health, particularly its potential adverse effects. Patients may benefit from insights that could lead to improved treatments for bone-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions affecting bone density, such as osteopenia or osteoporosis.
Not a fit: Patients with no bone health issues or those not taking medications that affect bone metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment of bone diseases, potentially improving bone health and reducing the risk of fractures.
How similar studies have performed: Previous research has shown promising results in understanding bone cell signaling, suggesting that this approach could yield valuable insights.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Thompson, William Roy — Indiana University Indianapolis
- Study coordinator: Thompson, William Roy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.